GIHCG and hepatocellular carcinoma: The lncRNA GIHCG (GIHCG Inhibitor of MiR-200b/200a/429 Expression) promotes the proliferation and metastasis of hepatoma cells by increasing histone H3K27 methylation in the promoter region of miR-200b/a/429, thereby silencing the expression of miR-200b/a/429 [61].